The landscape of dementia diagnosis has evolved significantly with the appearance of refined biomarkers, including amyloid PET scans, tau imaging, and blood-dependent tests that will detect Alzheimer's pathology decades just before symptoms emerge. Even though these technological advances depict outstanding progress in knowledge neurodegenerative d